These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 11303595

  • 1. Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breast.
    Hoque A, Lippman SM, Boiko IV, Atkinson EN, Sneige N, Sahin A, Weber DM, Risin S, Lagios MD, Schwarting R, Colburn WJ, Dhingra K, Follen M, Kelloff GJ, Boone CW, Hittelman WN.
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):249-59. PubMed ID: 11303595
    [Abstract] [Full Text] [Related]

  • 2. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
    Boyages J, Delaney G, Taylor R.
    Cancer; 1999 Feb 01; 85(3):616-28. PubMed ID: 10091735
    [Abstract] [Full Text] [Related]

  • 3. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M.
    Breast Cancer Res Treat; 2008 Jun 01; 109(3):405-16. PubMed ID: 17687650
    [Abstract] [Full Text] [Related]

  • 4. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL.
    APMIS Suppl; 2003 Jun 01; (108):1-67. PubMed ID: 12874968
    [Abstract] [Full Text] [Related]

  • 5. Correlation of nuclear morphometry with pathologic parameters in ductal carcinoma in situ of the breast.
    Tan PH, Goh BB, Chiang G, Bay BH.
    Mod Pathol; 2001 Oct 01; 14(10):937-41. PubMed ID: 11598161
    [Abstract] [Full Text] [Related]

  • 6. Histological markers that predict clinical recurrence in ductal carcinoma in situ of the breast: an Australian population-based study.
    Provenzano E, Hopper JL, Giles GG, Marr G, Venter DJ, Armes JE.
    Pathology; 2004 Jun 01; 36(3):221-9. PubMed ID: 15203725
    [Abstract] [Full Text] [Related]

  • 7. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI, Malone KE, Saltzman BS, Daling JR.
    Cancer; 2006 May 15; 106(10):2104-12. PubMed ID: 16604564
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Impact of estrogen receptor expression and other clinicopathologic features on tamoxifen use in ductal carcinoma in situ.
    Hird RB, Chang A, Cimmino V, Diehl K, Sabel M, Kleer C, Helvie M, Schott A, Young J, Hayes D, Newman L.
    Cancer; 2006 May 15; 106(10):2113-8. PubMed ID: 16596655
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
    Sahoo S, Recant WM, Jaskowiak N, Tong L, Heimann R.
    Breast J; 2005 May 15; 11(4):242-7. PubMed ID: 15982389
    [Abstract] [Full Text] [Related]

  • 12. The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone.
    Cornfield DB, Palazzo JP, Schwartz GF, Goonewardene SA, Kovatich AJ, Chervoneva I, Hyslop T, Schwarting R.
    Cancer; 2004 Jun 01; 100(11):2317-27. PubMed ID: 15160334
    [Abstract] [Full Text] [Related]

  • 13. Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study.
    Collins LC, Tamimi RM, Baer HJ, Connolly JL, Colditz GA, Schnitt SJ.
    Cancer; 2005 May 01; 103(9):1778-84. PubMed ID: 15770688
    [Abstract] [Full Text] [Related]

  • 14. [Bilateral ductal carcinoma in situ of the breast: independent events or bilateral disease?].
    André G, Tunon-de-Lara C, Macgrogan G, Laharie-Mineur H, Bussieres JE, Valentin F, Barreau B, Dilhuydy MH, Dilhuydy JM, Mauriac L, Debled M, Durand M, Mathoulin S, Avril A.
    J Gynecol Obstet Biol Reprod (Paris); 2007 May 01; 36(3):260-6. PubMed ID: 17376610
    [Abstract] [Full Text] [Related]

  • 15. Risk of recurrence after ductal carcinoma in situ of the breast.
    Habel LA, Daling JR, Newcomb PA, Self SG, Porter PL, Stanford JL, Seidel K, Weiss NS.
    Cancer Epidemiol Biomarkers Prev; 1998 Aug 01; 7(8):689-96. PubMed ID: 9718221
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.
    Cabioglu N, Krishnamurthy S, Kuerer HM, Hunt KK, Singletary SE, Meric-Bernstam F, Ross MI, Feig BW, Ames FC, Babiera GV.
    Cancer; 2004 Aug 01; 101(3):508-17. PubMed ID: 15274063
    [Abstract] [Full Text] [Related]

  • 19. Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins.
    MacDonald HR, Silverstein MJ, Mabry H, Moorthy B, Ye W, Epstein MS, Holmes D, Silberman H, Lagios M.
    Am J Surg; 2005 Oct 01; 190(4):521-5. PubMed ID: 16164913
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.